SGOALS: Sleep Goal-focused Online Access to Lifestyle Support

Sponsor
University of Pittsburgh (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05942326
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH)
40
1
2
16
2.5

Study Details

Study Description

Brief Summary

The overall goal of the study is to develop a novel weight loss intervention for postpartum people by providing strategies to improve sleep, diet, and physical activity behaviors. In this study, we will recruitment and enroll 40 postpartum people and randomize them to receive the Sleep GOALS intervention or education control to evaluate the intervention's feasibility, acceptability, and preliminary efficacy.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Sleep GOALS
  • Behavioral: Education
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
16-week pilot study will use a single-blind, parallel-arm randomized controlled trial design. Participants will be randomized at a 1:1 ratio to Sleep GOALS intervention (n=20) or an education control group (n=20)16-week pilot study will use a single-blind, parallel-arm randomized controlled trial design. Participants will be randomized at a 1:1 ratio to Sleep GOALS intervention (n=20) or an education control group (n=20)
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Sleep GOALS (Goal-focused Online Access to Lifestyle Support), an Internet Assisted Diet, Physical Activity, and Sleep Weight Loss Intervention for Postpartum Women
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sleep GOALS

Weekly 15-to-20 minute educational video each, a commercial activity tracker (e.g., Fitbit) to monitor sleep and physical activity, wireless scale to monitor weight, and a lifestyle coach who will provide personalized support.

Behavioral: Sleep GOALS
Web-based interventions

Active Comparator: Education

Brochures that provide tips for improving sleep health, diet, and physical activity

Behavioral: Education
Brochures from the American Academy of Sleep Medicine (e.g., sleep hygiene, sleep in women) and SNAP education connection (e.g., family-friendly activities, meal planning)

Outcome Measures

Primary Outcome Measures

  1. Recruitment/Enrollment - Number of the total sample [Baseline]

    The number of participants enrolled in 12 months

  2. Recruitment/Enrollment - Proportion of ethnic minority [Baseline]

    The proportion of ethnic minority

  3. Retention rates [Post-intervention at week 17]

    1-Attrition rates, % with complete post-intervention data collection

  4. Engagement - Number of modules completed [Week 1 to 16]

    The number of modules completed within 16 weeks

  5. Engagement - Number of self-monitoring of diet, sleep and physical activity weekly [Week 1 to 16]

    The number of weeks in which self-monitoring of diet, sleep, and physical activity is performed at least once a week

  6. Engagement - Number of weekly weigh-ins [Week 1 to 16]

    The number of weeks in which weigh-in is performed at least once a week

  7. Engagement - Total time logged in [Week 1 to 16]

    Total time logged in during the 16-week intervention

  8. Acceptability - Proportion of agreeing [Week 1 to Post-intervention at week 17]

    Participant ratings on the intervention delivery; behavior change curricula; action plan; intervention platform. The questionnaire asks participants to provide answers on a 5-point scale (1=don't agree at all to 5=totally agree) to 39 items about the intervention delivery (e.g., logical, understandable), curricula (e.g., was it logical, relevant, instructive), action plans (e.g., useful, easy to follow), and intervention platform (e.g., user friendly).

Secondary Outcome Measures

  1. Weight change [Baseline and Post-intervention at week 17]

    Baseline and post-intervention differences in weight. Weight will be measured with a digital scale, with the participant wearing light clothing and no shoes at baseline and post-intervention.

  2. Postpartum weight retention [Post-intervention at week 17]

    Pre-pregnancy and post-intervention differences in weight. Participants will self-report pre-pregnancy weight, and post-intervention weight will be measured with a digital scale, with the participant wearing light clothing and no shoes. The power-to-weight ratio (PWR) will be estimated as the difference in measured weight at post-intervention and self-reported pre-pregnancy weight.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Stated willingness to comply with all study procedures and availability for the duration of the study,

  • Primiparous, singleton pregnancy,

  • Between 3+1 and 6+1 months postpartum,

  • Has a body mass index >25 kg/m2,

  • Physically inactive, defined as self-reporting <150 minutes/week of moderate-to-vigorous intensity physical activity,

  • Endorse >1 indicator of poor sleep health based on the RU_SATED questionnaire, and

  • Has smartphone and home Internet access

Exclusion Criteria:
  • current use of medications that affect weight,

  • currently pregnant or plan to become pregnant during the study period (18 weeks), and

  • participating in another weight loss intervention.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pittsburgh Pittsburgh Pennsylvania United States 15261

Sponsors and Collaborators

  • University of Pittsburgh
  • National Heart, Lung, and Blood Institute (NHLBI)

Investigators

  • Principal Investigator: Marquis Hawkins, PhD, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marquis Hawkins, Assistant Professor, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT05942326
Other Study ID Numbers:
  • STUDY23020169
  • 1K01HL161439-01
First Posted:
Jul 12, 2023
Last Update Posted:
Jul 12, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2023